SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-012897
Filing Date
2023-08-02
Accepted
2023-08-02 16:02:22
Documents
105
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bpmc-20230630x10q.htm   iXBRL 10-Q 3083897
2 EX-10.1 bpmc-20230630xex10d1.htm EX-10.1 20204
3 EX-10.2 bpmc-20230630xex10d2.htm EX-10.2 22022
4 EX-31.1 bpmc-20230630xex31d1.htm EX-31.1 11335
5 EX-31.2 bpmc-20230630xex31d2.htm EX-31.2 11406
6 EX-32.1 bpmc-20230630xex32d1.htm EX-32.1 10655
  Complete submission text file 0001558370-23-012897.txt   11453181

Data Files

Seq Description Document Type Size
7 EX-101.SCH bpmc-20230630.xsd EX-101.SCH 84501
8 EX-101.CAL bpmc-20230630_cal.xml EX-101.CAL 68836
9 EX-101.DEF bpmc-20230630_def.xml EX-101.DEF 319253
10 EX-101.LAB bpmc-20230630_lab.xml EX-101.LAB 623966
11 EX-101.PRE bpmc-20230630_pre.xml EX-101.PRE 553591
99 EXTRACTED XBRL INSTANCE DOCUMENT bpmc-20230630x10q_htm.xml XML 2050861
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37359 | Film No.: 231135420
SIC: 2834 Pharmaceutical Preparations